Health IT, Devices & Diagnostics

One way the next generation of angel investors is acting more like VCs (and it’s actually a good thing)

“Traditionally we waited for folks to come to us.”

Queen City Angels MedCity INVEST

Angel investors are moving upstream. So where do they get their early-stage dealflow?

Dan Kincaid, a member of Queen City Angels in Cincinnati, said his organization is making-early stage bets by helping hatch companies through increased collaboration with local technology accelerators and tech transfer offices.

“Traditionally we waited for folks to come to us,” Kincaid, who spoke at MedCity INVEST on Tuesday.

Building companies through collaboration is more of a trend associated with corporate venture, tech transfer and venture funds. But in part because of the desire to cut their risks, angels are also trying to collaborate and launch companies after close work with academic medical centers and accelerators.

Kincaid has taken over as CEO for Sense Diagnostics, a disposable device that continuously monitors brain activity primarily in the intensive care unit, after he and other angels reviewed the opportunity with the University of Cincinnati (which, at the same time as local angels were being more proactive, the university tech transfer office was streamlining).

“That gives us a good view on promising companies coming out of the university,” Kincaid said, and the angels in turn help with commercialization plans, mentoring and SBIR grantwriting.

presented by

Queen City Angels is about to begin investing from a new $10 million angel fund (Kincaid estimates half of that capital will go to healthcare companies).

You can watch the entire conversation with Kincaid at INVEST in the video below.

[youtube https://www.youtube.com/watch?v=2Ezj3HtZNpA]